Biological and mechanical implications of PEGylating proteins into hydrogel biomaterials

Biomaterials

Volumn 32, Issue 26, 2011, Pages 6025-6033

  Gonen Wadmany, Maya ^a   Goldshmid, Revital ^a   Seliktar, Dror ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Fibrinogen; Fibroblast; Hydrogel; Polymer; Scaffold

Indexed keywords

3-D CULTURE SYSTEM; BIOFUNCTIONALITY; BIOLOGICAL COMPATIBILITY; BIOPHYSICAL CHARACTERISTICS; CELL CULTIVATION; CELLULAR MORPHOLOGY; FIBRINOGEN; HYDROGEL SCAFFOLDS; MATRIX METALLOPROTEINASES; MICROENVIRONMENTS; PEGYLATION; POLYMER CHAINS; PROTEIN PEGYLATION; TWO-MATERIALS;

BIOCOMPATIBILITY; BIODEGRADATION; BIOLOGICAL MATERIALS; BIOMECHANICS; CELL CULTURE; CROSSLINKING; ENZYME ACTIVITY; FIBROBLASTS; GLYCOLS; MECHANICAL PROPERTIES; MORPHOLOGY; PROTEINS; SCAFFOLDS (BIOLOGY); THREE DIMENSIONAL;

HYDROGELS;

ACTIN; BIOMATERIAL; FIBRIN; FIBRINOGEN; MACROGOL; MATRIX METALLOPROTEINASE; PEGYLATED FIBRINOGEN; POLYMER; PROTEIN; SCAFFOLD PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL PROLIFERATION; CELL STRUCTURE; COCULTURE; CONJUGATION; CROSS LINKING; FIBROBLAST; HUMAN; HUMAN CELL; HYDROGEL; MALE; NEWBORN; PERFORMANCE; PREPUCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CELLS, CULTURED; FIBRINOGEN; FIBROBLASTS; HUMANS; HYDROGEL; IMMUNOHISTOCHEMISTRY; POLYETHYLENE GLYCOLS; TISSUE ENGINEERING;

EID: 79959868167     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.055     Document Type: Article

References (34)

1. Lee K.Y., Mooney D.J. Hydrogels for tissue engineering. Chem Rev 2001, 101(7):1869-1879.
2. Herrick S., Blanc-Brude O., Gray A., Laurent G. Fibrinogen. Int J Biochem Cell Biol 1999, 31(7):741-746.
3. Ahmed T.A., Dare E.V., Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008, 14(2):199-215.
4. Scheraga H.A. The thrombin-fibrinogen interaction. Biophys Chem 2004, 112(2-3):117-130.
5. Jockenhoevel S., Zund G., Hoerstrup S.P., Chalabi K., Sachweh J.S., Demircan L., et al. Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2001, 19(4):424-430.
6. Seliktar D. Extracellular stimulation in tissue engineering. Ann N Y Acad Sci 2005, 1047:386-394.
7. Almany L., Seliktar D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 2005, 26(15):2467-2477.
8. Gonen-Wadmany M., Oss-Ronen L., Seliktar D. Protein-polymer conjugates for forming photopolymerizable biomimetic hydrogels for tissue engineering. Biomaterials 2007, 28(26):3876-3886.
9. Peppas N.A., Huang Y., Torres-Lugo M., Ward J.H., Zhang J. Physicochemical foundations and structural design of hydrogels in medicine and biology. Annu Rev Biomed Eng 2000, 2:9-29.
10. Appelman T.P., Mizrahi J., Elisseeff J.H., Seliktar D. The differential effect of scaffold composition and architecture on chondrocyte response to mechanical stimulation. Biomaterials 2009, 30(4):518-525.
11. Dikovsky D., Bianco-Peled H., Seliktar D. The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. Biomaterials 2006, 27(8):1496-1506.
12. Dikovsky D., Bianco-Peled H., Seliktar D. Defining the role of matrix compliance and proteolysis in three-dimensional cell spreading and remodeling. Biophys J 2008, 94(7):2914-2925.
13. Sarig-Nadir O., Seliktar D. Compositional alterations of fibrin-based materials for regulating in vitro neural outgrowth. Tissue Eng Part A 2008, 14(3):401-411.
14. Shapira K., Dikovsky D., Habib M., Gepstein L., Seliktar D. Hydrogels for cardiac tissue regeneration. Biomed Mater Eng 2008, 18(4-5):309-314.
15. Drinnan C.T., Zhang G., Alexander M.A., Pulido A.S., Suggs L.J. Multimodal release of transforming growth factor-beta1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. J Control Release 2010, 147(2):180-186.
16. Kim P.D., Peyton S.R., VanStrien A.J., Putnam A.J. The influence of ascorbic acid, TGF-beta1, and cell-mediated remodeling on the bulk mechanical properties of 3-D PEG-fibrinogen constructs. Biomaterials 2009, 30(23-24):3854-3864.
17. Barker T.H., Fuller G.M., Klinger M.M., Feldman D.S., Hagood J.S. Modification of fibrinogen with poly(ethylene glycol) and its effects on fibrin clot characteristics. J Biomed Mater Res 2001, 56(4):529-535.
18. Veronese F.M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 2001, 22(5):405-417.
19. Bailon P., Berthold W. Polyethylene glycol-conjugated pharmaceutical proteins. PSTT 1998, 1(8):352-356.
20. Fung W.-J., Porter J.E., Bailon P. Strategies for the preparation and characterization of polyethylene glycol (PEG) conjugated pharmaceutical proteins. Polym Prepr 1997, 38(1):565-566.
21. Halstenberg S., Panitch A., Rizzi S., Hall H., Hubbell J.A. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules 2002, 3(4):710-723.
22. Ye Q., Zund G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000, 17(5):587-591.
23. Lin C.C., Anseth K.S. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 2009, 26(3):631-643.
24. Veronese F.M., Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 2005, 10(21):1451-1458.
25. Farran A.J., Teller S.S., Jha A.K., Jiao T., Hule R.A., Clifton R.J., et al. Effects of matrix composition, microstructure, and viscoelasticity on the behaviors of vocal fold fibroblasts cultured in three-dimensional hydrogel networks. Tissue Eng Part A 2010, 16(4):1247-1261.
26. Pedersen J.A., Swartz M.A. Mechanobiology in the third dimension. Ann Biomed Eng 2005, 33(11):1469-1490.
27. Peyton S.R., Kim P.D., Ghajar C.M., Seliktar D., Putnam A.J. The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials 2008, 29(17):2597-2607.
28. Zhang G., Wang X., Wang Z., Zhang J., Suggs L. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng 2006, 12(1):9-19.
29. Yu S., Sher B., Kudryk B., Redman C.M. Fibrinogen precursors. Order of assembly of fibrinogen chains. J Biol Chem 1984, 259(16):10574-10581.
30. Cox S., Cole M., Tawil B. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Eng 2004, 10(5-6):942-954.
31. Hong H., Stegemann J.P. 2D and 3D collagen and fibrin biopolymers promote specific ECM and integrin gene expression by vascular smooth muscle cells. J Biomater Sci Polym Ed 2008, 19(10):1279-1293.
32. O'Cearbhaill E.D., Murphy M., Barry F., McHugh P.E., Barron V. Behavior of human mesenchymal stem cells in fibrin-based vascular tissue engineering constructs. Ann Biomed Eng 2010, 38(3):649-657.
33. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
34. Raeber G.P., Lutolf M.P., Hubbell J.A. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005, 89(2):1374-1388.